1Bonifacio E, Lampasona V, Genovese S, et al. Identification of protein tyrosine phosphatase-like IA-2 (islet cell antigen 512) as the insulin dependent diabetes-related 37/40Kautoantigen and a target of islet-cell antibodies [J]. J Immunol 1995,155:5419-5
2Yoon J W , Jun H S & Santamaria P S. Cellular and molecular mechanisms for the initiation and progression of-cell destruction resulting from the collaboration between macrophages and T cells[J]. Autoimmunity 1998,27: 109-122.
3Ji-Won Yoon, Hee-Sook Jun. Cellular and molecular pathogenic mechanisms of insulin-dependent diabetes mellitus [J]. Annals of The New York Academy of Sciences 2001,928:200-211.
4Zekzer D, F S Wong, O Ayalon, etal. GAD-reactive CD4+Th1cells induce diabetes in NOD/SCID mice [J]. Clin Invest 1998,101: 68-73.
5Su, HuXO, Kristan J M, etal. Signiacant role for fas in the pathogenesis of autoimmune diabetes [J]. J Immunol 2000,164: 2523-2532.
6Hayan S, Guillermo A A. Regulatory natural killer T cells protect against spontaneous and recunent type 1 diabetes [J]. Annals of the New York Academy of Sciences 2002, 958:77-88.
7O Herrin SM, Slansky JE, Tang Q, et al. Antigen-specific blockade of T cells in vivo using dimeric MHC peptide [J].J Immunol 2001,14:195-200.
8Emma L M, Jeffrey A B. Immunotherapy of insulin-dependent diabetes mellitus[J]. Current Opinion in Immunology 2002, 14:652-659.
9Jean-Francois Bach and Lucienne Chatenoud. Tolerance to islet autoantigens in type 1diabetes[J]. Annu Rev Immunol 2001,19:131-161.
10Bach J F, Chatenoud L. Tolerance to islet autoantigens in type 1 diabetes. Annu[J]. Rev Immunol 2001,19:131-161.
